Related Experiment Video
Updated: Apr 7, 2026
A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024
Next Generation of Preclinical Liver Cancer Models
Achim Weber1, Tracy O'Connor2, Mathias Heikenwalder3
1Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland.
Abstract:
Because of its heterogeneity, lack of prognostic markers, tumor-escape mechanisms, and frequent relapse upon surgical intervention, treatment of hepatocellular carcinoma (HCC) remains challenging. In this issue of Clinical Cancer Research, Groß and colleagues characterize a rodent model that might help identify novel drugs for combinatorial sorafenib-based therapies for HCC.
Insights
Hepatocellular carcinoma (HCC) treatment is difficult due to its complex nature and resistance to therapies. A new rodent model offers a promising tool for discovering novel combination drugs to improve sorafenib-based treatments for HCC.
Area of Science:
- Oncology
- Translational Research
- Animal Models
Background:
- Hepatocellular carcinoma (HCC) presents significant therapeutic challenges owing to its cellular heterogeneity, absence of reliable prognostic markers, and tumor evasion strategies.
- Surgical interventions for HCC are frequently followed by tumor relapse, underscoring the need for more effective systemic treatments.
Discussion:
- The study introduces a novel rodent model for hepatocellular carcinoma (HCC) research.
- This model is designed to facilitate the identification of new therapeutic agents.
- It aims to support the development of combination therapies involving sorafenib.
Key Insights:
- Characterization of a new rodent model for studying hepatocellular carcinoma (HCC).
- The model serves as a platform for preclinical drug discovery in HCC.
- Potential for identifying novel agents to enhance sorafenib efficacy in HCC treatment.
Outlook:
- The developed rodent model is expected to accelerate the discovery of effective combinatorial treatments for HCC.
- This research may lead to improved therapeutic strategies for patients with hepatocellular carcinoma.
- Further studies using this model could refine sorafenib-based regimens and explore new drug combinations.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
11:43Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones
Published on: November 30, 2016
